ADMA
NASDAQ · Biotechnology
Adma Biologics Inc
$9.63
-1.70 (-15.00%)
Performance
1D
—
1W
—
1M
—
3M
-50.05%
6M
-34.49%
1Y
-51.12%
YTD
-46.14%
Open$11.45
Previous Close$11.33
Day High$11.45
Day Low$8.62
52W High$25.67
52W Low$13.50
Volume—
Avg Volume1.93M
Market Cap3.83B
P/E Ratio18.29
EPS$0.85
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$17.86
Below
SMA 200
$17.61
Below
RSI (14)
42.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
9 analysts
Price Target
+265.7% upside
Current
$9.63
$9.63
Target
$35.22
$35.22
$21.76
$35.22 avg
$46.82
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 408.22M | 234.55M | 922.90M |
| Net Income | 189.21M | 97.85M | -95,808,796 |
| Profit Margin | 46.4% | 44.0% | -10.4% |
| EBITDA | 132.03M | 72.07M | -107,012,515 |
| Free Cash Flow | — | — | -83,155,340 |
| Rev Growth | +74.0% | +74.0% | +20.1% |
| Debt/Equity | 0.21 | 0.21 | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |